Laleh Khodadadi

1.1k total citations
11 papers, 419 citations indexed

About

Laleh Khodadadi is a scholar working on Immunology, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Laleh Khodadadi has authored 11 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Rheumatology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Laleh Khodadadi's work include T-cell and B-cell Immunology (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Laleh Khodadadi is often cited by papers focused on T-cell and B-cell Immunology (8 papers), Systemic Lupus Erythematosus Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Laleh Khodadadi collaborates with scholars based in Germany. Laleh Khodadadi's co-authors include Falk Hiepe, Andreas Radbruch, Qingyu Cheng, Bimba F. Hoyer, Tobias Alexander, Jens Klotsche, Adriano Taddeo, Imtiaz M Mumtaz, Robert Biesen and Aderajew Waka and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Laleh Khodadadi

10 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laleh Khodadadi Germany 8 263 145 68 55 52 11 419
Janne Ø. Bohnhorst Norway 6 386 1.5× 108 0.7× 55 0.8× 87 1.6× 70 1.3× 6 576
Agapitos Patakas United Kingdom 10 316 1.2× 96 0.7× 63 0.9× 76 1.4× 50 1.0× 12 425
Christopher T. Richardson United States 12 162 0.6× 110 0.8× 46 0.7× 28 0.5× 76 1.5× 38 395
Paul D. Doodes United States 7 492 1.9× 168 1.2× 125 1.8× 119 2.2× 51 1.0× 7 652
William Loo United States 9 249 0.9× 79 0.5× 56 0.8× 33 0.6× 68 1.3× 11 382
Jean‐Nicolas Schickel United States 10 307 1.2× 64 0.4× 39 0.6× 68 1.2× 110 2.1× 12 438
Edith Roth Germany 10 392 1.5× 80 0.6× 70 1.0× 55 1.0× 192 3.7× 19 603
Maud Maho‐Vaillant France 7 256 1.0× 65 0.4× 40 0.6× 30 0.5× 33 0.6× 15 403
Floris C. Loeff Netherlands 9 125 0.5× 64 0.4× 47 0.7× 37 0.7× 52 1.0× 23 331
M Canova Italy 5 160 0.6× 185 1.3× 32 0.5× 25 0.5× 55 1.1× 5 370

Countries citing papers authored by Laleh Khodadadi

Since Specialization
Citations

This map shows the geographic impact of Laleh Khodadadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laleh Khodadadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laleh Khodadadi more than expected).

Fields of papers citing papers by Laleh Khodadadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laleh Khodadadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laleh Khodadadi. The network helps show where Laleh Khodadadi may publish in the future.

Co-authorship network of co-authors of Laleh Khodadadi

This figure shows the co-authorship network connecting the top 25 collaborators of Laleh Khodadadi. A scholar is included among the top collaborators of Laleh Khodadadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laleh Khodadadi. Laleh Khodadadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Alexander, Tobias, Lennard Ostendorf, Jens Klotsche, et al.. (2024). LBA0007 SAFETY AND EFFICACY OF DARATUMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS – A SINGLE-CENTER PHASE 2 OPEN-LABEL TRIAL. Annals of the Rheumatic Diseases. 83. 237–238.
2.
Chang, Hyun‐Dong, Koji Tokoyoda, Bimba F. Hoyer, et al.. (2019). Pathogenic memory plasma cells in autoimmunity. Current Opinion in Immunology. 61. 86–91. 26 indexed citations
3.
Khodadadi, Laleh, Qingyu Cheng, Andreas Radbruch, & Falk Hiepe. (2019). The Maintenance of Memory Plasma Cells. Frontiers in Immunology. 10. 721–721. 130 indexed citations
4.
Cheng, Qingyu, Andreas Pelz, Bimba F. Hoyer, et al.. (2019). AB0028 SELECTIVE DEPLETION OF PLASMA CELLS IN VIVOBASED ON SPECIFICITY OF SECRETED ANTIBODIES. Annals of the Rheumatic Diseases. 78. 1479–1479. 1 indexed citations
5.
Cheng, Qingyu, Andreas Pelz, Adriano Taddeo, et al.. (2019). Selective depletion of plasma cells in vivo based on the specificity of their secreted antibodies. European Journal of Immunology. 50(2). 284–291. 21 indexed citations
6.
Alexander, Tobias, Qingyu Cheng, Jens Klotsche, et al.. (2018). Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors. European Journal of Immunology. 48(9). 1573–1579. 53 indexed citations
7.
Cheng, Qingyu, Laleh Khodadadi, Adriano Taddeo, et al.. (2018). CXCR4–CXCL12 interaction is important for plasma cell homing and survival in NZB/W mice. European Journal of Immunology. 48(6). 1020–1029. 41 indexed citations
8.
Khodadadi, Laleh, Qingyu Cheng, Tobias Alexander, et al.. (2015). Bortezomib Plus Continuous B Cell Depletion Results in Sustained Plasma Cell Depletion and Amelioration of Lupus Nephritis in NZB/W F1 Mice. PLoS ONE. 10(8). e0135081–e0135081. 40 indexed citations
9.
10.
Winter, Oliver, et al.. (2015). Analyzing pathogenic (double-stranded (ds) DNA-specific) plasma cells via immunofluorescence microscopy. Arthritis Research & Therapy. 17(1). 293–293. 6 indexed citations
11.
Cheng, Qingyu, Imtiaz M Mumtaz, Laleh Khodadadi, et al.. (2013). Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis. Annals of the Rheumatic Diseases. 72(12). 2011–2017. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janne Ø. Bohnhorst Breakdown of academic impact, for papers by Agapitos Patakas Breakdown of academic impact, for papers by Christopher T. Richardson Breakdown of academic impact, for papers by Paul D. Doodes Breakdown of academic impact, for papers by William Loo Breakdown of academic impact, for papers by Jean‐Nicolas Schickel Breakdown of academic impact, for papers by Edith Roth Breakdown of academic impact, for papers by Maud Maho‐Vaillant Breakdown of academic impact, for papers by Floris C. Loeff Breakdown of academic impact, for papers by M Canova
Rankless by CCL
2026